Dormant Company Accounts - NUCANA BIOMED TRUSTEE COMPANY LIMITED

Dormant Company Accounts - NUCANA BIOMED TRUSTEE COMPANY LIMITED


Companies House true 2022-01-01 2022-12-31 false SC412487 uk-bus:Director1 2022-01-01 2022-12-31 SC412487 uk-bus:Director2 2022-01-01 2022-12-31 SC412487 2022-01-01 2022-12-31 SC412487 2022-12-31 SC412487 uk-bus:EntityHasNeverTraded 2022-01-01 2022-12-31 SC412487 uk-bus:FRS102 2022-01-01 2022-12-31 SC412487 uk-bus:FullAccounts 2022-01-01 2022-12-31 SC412487 uk-bus:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 SC412487 2021-12-31 SC412487 uk-bus:OrdinaryShareClass1 2022-01-01 2022-12-31 SC412487 uk-bus:OrdinaryShareClass2 2022-01-01 2022-12-31 SC412487 uk-bus:OrdinaryShareClass3 2022-01-01 2022-12-31 SC412487 uk-bus:PreferenceShareClass1 2022-01-01 2022-12-31 SC412487 uk-bus:PreferenceShareClass2 2022-01-01 2022-12-31 SC412487 uk-bus:PreferenceShareClass3 2022-01-01 2022-12-31 SC412487 uk-core:ShareCapitalPreferenceShares 2022-12-31 SC412487 uk-core:ShareCapitalPreferenceShares 2021-12-31 iso4217:GBP xbrli:shares

Registered Number SC412487

NUCANA BIOMED TRUSTEE COMPANY LIMITED

Dormant Accounts

31 December 2022

NUCANA BIOMED TRUSTEE COMPANY LIMITED Registered Number SC412487

Balance Sheet as at 31 December 2022

2022 2021
£ £
Current assets
Cash at bank and in hand
1
1
Net assets
1
1
Issued share capital
1 Ordinary Share of £ 1 each 1 1
Total Shareholder funds
1
1

STATEMENTS

  1. For the year ending 31 December 2022 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 22 August 2023

And signed on their behalf by:
Martin Quinn, Director